NCT03067441View on ClinicalTrials.gov

Assessment of the Long-Term Safety and Efficacy of Bempedoic Acid (CLEAR Harmony OLE)

PHASE3CompletedINTERVENTIONAL
Enrollment

1,462

Participants

Timeline

Start Date

February 3, 2017

Primary Completion Date

November 5, 2019

Study Completion Date

November 5, 2019

Conditions
HypercholesterolemiaAtherosclerotic Cardiovascular Disease
Interventions
DRUG

bempedoic acid

bempedoic acid 180 mg tablets taken orally, once per day.

Trial Locations (3)

33607

Jedidiah Clinical Research, Tampa

40213

L-MARC Research Center, Louisville

45236

Sentral Clinical Research Services, Cincinnati

Sponsors
All Listed Sponsors
lead

Esperion Therapeutics, Inc.

INDUSTRY